Last reviewed · How we verify

Natesto Nasal Product

University of Utah · FDA-approved active Small molecule Quality 2/100

Natesto Nasal Product is a Small molecule drug developed by University of Utah. It is currently FDA-approved. Also known as: Natesto Nasal Gel.

At a glance

Generic nameNatesto Nasal Product
Also known asNatesto Nasal Gel
SponsorUniversity of Utah
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Natesto Nasal Product

What is Natesto Nasal Product?

Natesto Nasal Product is a Small molecule drug developed by University of Utah.

Who makes Natesto Nasal Product?

Natesto Nasal Product is developed and marketed by University of Utah (see full University of Utah pipeline at /company/university-of-utah).

Is Natesto Nasal Product also known as anything else?

Natesto Nasal Product is also known as Natesto Nasal Gel.

What development phase is Natesto Nasal Product in?

Natesto Nasal Product is FDA-approved (marketed).

Related